Copyright Reports & Markets. All rights reserved.

Global Dasatinib Drugs Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Dasatinib Drugs

      • 1.1 Definition of Dasatinib Drugs
      • 1.2 Dasatinib Drugs Segment by Type
        • 1.2.1 Global Dasatinib Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 20mg
        • 1.2.3 50mg
        • 1.2.4 70mg
      • 1.3 Dasatinib Drugs Segment by Applications
        • 1.3.1 Global Dasatinib Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 CML
        • 1.3.3 ALL
      • 1.4 Global Dasatinib Drugs Overall Market
        • 1.4.1 Global Dasatinib Drugs Revenue (2014-2025)
        • 1.4.2 Global Dasatinib Drugs Production (2014-2025)
        • 1.4.3 North America Dasatinib Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Dasatinib Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Dasatinib Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Dasatinib Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Dasatinib Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Dasatinib Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Dasatinib Drugs
      • 2.3 Manufacturing Process Analysis of Dasatinib Drugs
      • 2.4 Industry Chain Structure of Dasatinib Drugs

      3 Development and Manufacturing Plants Analysis of Dasatinib Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Dasatinib Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Dasatinib Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Dasatinib Drugs Production and Capacity Analysis
      • 4.2 Dasatinib Drugs Revenue Analysis
      • 4.3 Dasatinib Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Dasatinib Drugs Regional Market Analysis

      • 5.1 Dasatinib Drugs Production by Regions
        • 5.1.1 Global Dasatinib Drugs Production by Regions
        • 5.1.2 Global Dasatinib Drugs Revenue by Regions
      • 5.2 Dasatinib Drugs Consumption by Regions
      • 5.3 North America Dasatinib Drugs Market Analysis
        • 5.3.1 North America Dasatinib Drugs Production
        • 5.3.2 North America Dasatinib Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Dasatinib Drugs Import and Export
      • 5.4 Europe Dasatinib Drugs Market Analysis
        • 5.4.1 Europe Dasatinib Drugs Production
        • 5.4.2 Europe Dasatinib Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Dasatinib Drugs Import and Export
      • 5.5 China Dasatinib Drugs Market Analysis
        • 5.5.1 China Dasatinib Drugs Production
        • 5.5.2 China Dasatinib Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Dasatinib Drugs Import and Export
      • 5.6 Japan Dasatinib Drugs Market Analysis
        • 5.6.1 Japan Dasatinib Drugs Production
        • 5.6.2 Japan Dasatinib Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Dasatinib Drugs Import and Export
      • 5.7 Southeast Asia Dasatinib Drugs Market Analysis
        • 5.7.1 Southeast Asia Dasatinib Drugs Production
        • 5.7.2 Southeast Asia Dasatinib Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Dasatinib Drugs Import and Export
      • 5.8 India Dasatinib Drugs Market Analysis
        • 5.8.1 India Dasatinib Drugs Production
        • 5.8.2 India Dasatinib Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Dasatinib Drugs Import and Export

      6 Dasatinib Drugs Segment Market Analysis (by Type)

      • 6.1 Global Dasatinib Drugs Production by Type
      • 6.2 Global Dasatinib Drugs Revenue by Type
      • 6.3 Dasatinib Drugs Price by Type

      7 Dasatinib Drugs Segment Market Analysis (by Application)

      • 7.1 Global Dasatinib Drugs Consumption by Application
      • 7.2 Global Dasatinib Drugs Consumption Market Share by Application (2014-2019)

      8 Dasatinib Drugs Major Manufacturers Analysis

      • 8.1 Bristol-Myers Squibb
        • 8.1.1 Bristol-Myers Squibb Dasatinib Drugs Production Sites and Area Served
        • 8.1.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.1.3 Bristol-Myers Squibb Dasatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 LUCIUS Pharma
        • 8.2.1 LUCIUS Pharma Dasatinib Drugs Production Sites and Area Served
        • 8.2.2 LUCIUS Pharma Product Introduction, Application and Specification
        • 8.2.3 LUCIUS Pharma Dasatinib Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served

      9 Development Trend of Analysis of Dasatinib Drugs Market

      • 9.1 Global Dasatinib Drugs Market Trend Analysis
        • 9.1.1 Global Dasatinib Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Dasatinib Drugs Regional Market Trend
        • 9.2.1 North America Dasatinib Drugs Forecast 2019-2025
        • 9.2.2 Europe Dasatinib Drugs Forecast 2019-2025
        • 9.2.3 China Dasatinib Drugs Forecast 2019-2025
        • 9.2.4 Japan Dasatinib Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Dasatinib Drugs Forecast 2019-2025
        • 9.2.6 India Dasatinib Drugs Forecast 2019-2025
      • 9.3 Dasatinib Drugs Market Trend (Product Type)
      • 9.4 Dasatinib Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Dasatinib Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).

        The global Dasatinib Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Dasatinib Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dasatinib Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Dasatinib Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Dasatinib Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Bristol-Myers Squibb
        LUCIUS Pharma
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        20mg
        50mg
        70mg

        Segment by Application
        CML
        ALL

        Buy now